A detailed history of Quent Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Quent Capital, LLC holds 5,401 shares of ABT stock, worth $615,768. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,401
Previous 5,155 4.77%
Holding current value
$615,768
Previous $585,000 4.1%
% of portfolio
0.06%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$100.73 - $112.44 $24,779 - $27,660
246 Added 4.77%
5,401 $561,000
Q1 2024

Jun 28, 2024

SELL
$109.52 - $120.96 $109 - $120
-1 Reduced 0.02%
5,155 $585,000
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $876 - $967
8 Added 0.16%
5,156 $586,000
Q4 2023

Jun 14, 2024

BUY
$90.19 - $110.4 $68,544 - $83,904
760 Added 17.32%
5,148 $566,000
Q4 2023

Jan 19, 2024

BUY
$90.19 - $110.4 $68,544 - $83,904
760 Added 17.32%
5,148 $566,000
Q3 2023

Jun 14, 2024

SELL
$95.53 - $114.62 $8,215 - $9,857
-86 Reduced 1.92%
4,388 $424,000
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $8,215 - $9,857
-86 Reduced 1.92%
4,388 $424,000
Q2 2023

Jun 14, 2024

BUY
$100.78 - $112.29 $5,442 - $6,063
54 Added 1.22%
4,474 $487,000
Q2 2023

Jul 10, 2023

BUY
$100.78 - $112.29 $5,442 - $6,063
54 Added 1.22%
4,474 $487,000
Q1 2023

Jun 14, 2024

SELL
$96.86 - $114.01 $71,288 - $83,911
-736 Reduced 14.27%
4,420 $447,000
Q1 2023

Apr 05, 2023

BUY
$96.86 - $114.01 $44,361 - $52,216
458 Added 11.56%
4,420 $447,000
Q4 2022

Jan 19, 2023

SELL
$95.06 - $111.52 $19,487 - $22,861
-205 Reduced 4.92%
3,962 $0
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $67,732 - $78,421
700 Added 20.19%
4,167 $403,000
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $23,271 - $28,128
228 Added 7.04%
3,467 $377,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $173,652 - $211,757
1,523 Added 88.75%
3,239 $383,000
Q4 2021

Feb 28, 2022

BUY
$115.53 - $141.46 $198,249 - $242,745
1,716 New
1,716 $242,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.